Susquehanna International Group’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,899
| Closed | -$159K | – | 7150 |
|
|
2022
Q4 | $159K | Sell |
15,899
-1,800
| -10% | -$17.9K | ﹤0.01% | 4653 |
|
|
2022
Q3 | $175K | Sell |
17,699
-22,207
| -56% | -$220K | ﹤0.01% | 4913 |
|
|
2022
Q2 | $391K | Buy |
39,906
+10,539
| +36% | +$103K | ﹤0.01% | 3650 |
|
|
2022
Q1 | $288K | Hold |
29,367
| – | – | ﹤0.01% | 4399 |
|
|
2021
Q4 | $294K | Hold |
29,367
| – | – | ﹤0.01% | 4518 |
|
|
2021
Q3 | $294K | Hold |
29,367
| – | – | ﹤0.01% | 4319 |
|
|
2021
Q2 | $295K | Hold |
29,367
| – | – | ﹤0.01% | 4476 |
|
|
2021
Q1 | $290K | Buy |
+29,367
| New | +$290K | ﹤0.01% | 4399 |
|